Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

NATUREX won the 1st prize Deloitte Technology Fast 50 in the SMEs category, for its strong growth in 5 years



Avignon, 27 november 2012 - NATUREX, the global leader in speciality plant-based natural ingredients, was honored with the 1st prize Deloitte Technology Fast 50 in the category of SMEs1 for its 219% growth in 5 years during the awards ceremony held at the Palais Brongniart in Paris on 26 November.


The Deloitte Technology Fast 50 event rewards since 12 years, the 50 technology and innovative French companies which have experienced the highest growth rate of revenues over five years, from 2007 to 2011.


Such a distinction recognizes the strategy of both organic and external growth conducted by NATUREX since its creation, and underlines the strength of its position on international markets thanks to high value-added scientific expertise and technical know-how as well as a diversified and innovative offer.


 “We are very honored to have received this award, which highlights our performance over the last 5 years and confirms the relevance of our development strategy”, reported Thierry Lambert, Chairman and CEO of NATUREX. “I want to dedicate this award to our 1,300 employees around the world, our customers and our shareholders, for their confidence and loyalty, as well as their active involvement in the growth of NATUREX."


 


You can receive all financial information of Naturex free of charge by signing up at: www.naturex.com


 



  • Financial schedule







- Q3 2012 consolidated results 29 November 2012

 


Naturex has been listed on NYSE Euronext Paris, Compartment B (Mid Caps), since October 1996.






NATUREX Total number of shares comprising the share capital: 7,728,079

  • 7,141,509 ordinary shares (ISIN FR0000054694)

  • 586,570 preferred shares (ISIN FR0010833251)

Naturex is a component of the CAC Small and Gaïa indexes.

Naturex is eligible for "long only" Deferred Settlement Service (SRD).

Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY.



SYMBOL: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY

 


About Naturex


Naturex is the global leader in speciality plant-based natural ingredients.

The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets specialty plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.


Naturex's head office is based in Avignon. The company employs more than 1,300 people with high-performance manufacturing operations across 15 sites in Europe (France, Italy, Spain, the United Kingdom, Switzerland, Poland) as well as in Morocco, the United States, Brazil and Australia. It also has a global presence through a dedicated network of sales offices in 21 countries (France, Italy, Spain, Morocco, the United Kingdom, Belgium, Germany, Poland, Russia, U.A.E., Thailand, Singapore, Japan, China, Korea, Australia, the United States, Canada, Brazil, Mexico and India).


Naturex's development is supported by positive underlying trends linked to the fast-growing demand for natural products and its capacity to provide manufacturers customised solutions to meet the requirements of their end consumers. The Group's strength lies in its positioning with specific products which constitute niche markets, supported by strong sourcing capacity and sustained research & development.


 



  • Contacts











Thierry Lambert

Chairman and Chief Executive Officer

Tel: +33 (0)4 90 23 96 89

[email protected]

 

 
 
Carole Alexandre

Investor Relations

Tel: +33 (0)4 90 23 78 28

[email protected]
Anne Catherine Bonjour

Actus Finance Press Relations

Tel: +33 (0)1 53 67 36 93

[email protected]

 


1 SMEs : Small and Medium-sized Entreprises which sales accounted for over EUR 50 million in 2007


Information réglementée
Communiqués au titre de l'obligation d'information permanente :

- Autres communiqués

Communiqué intégral et original au format PDF :


http://www.actusnews.com/documents_communiques/ACTUS-0-30216-cp-naturex-271112.pdf

<!-- 90 -->

© Copyright Actusnews Wire

Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com

Receive by email the next press releases of the company by registering on www.actusnews.com, it's free


<br/><p>Quelle: <a href="http://www.actusnews.com/" target="_blank" rel="nofollow">Actusnews</a></p>
Like: 0
Teilen

Kommentare